Aprotinin in deep hypothermic circulatory arrest

Annals of Thoracic Surgery

Volumn 68, Issue 1, 1999, Pages 278-286

  Smith, Craig R ^a   Spanier, Talia B ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ;

CARDIOPULMONARY BYPASS; DRUG SAFETY; HEPARINIZATION; HUMAN; HYPOTHERMIA; OPEN HEART SURGERY; PRIORITY JOURNAL; REVIEW;

EID: 0032776365     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00518-4     Document Type: Article

References (66)

1. Bidstrup B.P., Royston D., Sapsford R.N., Taylor K.M. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg. 97:1989;372.
2. Royston D., Bidstrup B.P., Taylor K.M., Sapford R.N. Effect of aprotinin on need for blood transfusion after repeat open heart surgery. Lancet. 2:1987;1289-1291.
3. Cosgrove D.M. III, Heric B., Lyttle B.W., et al. Aprotinin therapy for re-operative myocardial revascularization a placebo-controlled study . Ann Thorac Surg. 54:1992;1031-1038.
4. Wachtfogel Y.T., Kucich U., Hack C.E., et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg. 106:1993;1-9.
5. Blauhut B., Gross C., Necek S., Doran J.E., Spath P., Lundsgaard-Hansen P. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 101:1991;958-967.
6. Boldt J., Knothe C., Zickmann B., Bill S., Dapper F., Hempelmann G. Platelet function in cardiac surgery influence of temperature and aprotinin . Ann Thorac Surg. 55:1993;652-658.
7. Westaby S. Coagulation disturbances in profound hypothermia the influence of anti-fibrinolytic therapy . Seminars in Thorac and Cardiovasc Surg. 9:1997;246-256.
8. Okita Y., Takamoto S., Ando M., et al. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin. Circulation. 96:(Suppl II):1997;II-376-II-381.
9. Westaby S. Safety and efficacy of aprotinin in profoundly hypothermic circulatory arrest. J Card Surg. 12:(Suppl):1997;207-213.
10. Hornick P., Taylor K.M. Is aprotinin safe when used in the context of profound hypothermia and circulatory arrest? A literary review. J Heart Valve Dis. 4:1995;669-673.
11. Reed R.L. II, Bracey A.W. Jr, Hudson J.D., Miller T.A., Fischer R.P. Hypothermia and blood coagulation dissociation between enzyme activity and clotting factor levels . Circ Shock. 32:1990;141-152.
12. Kurrek M.M., Reed R.L. II. Effect of hypothermia on enzymatic activity of thrombin and plasmin. Surg Forum. 38:1987;221-223.
13. Kopriva C.J., Sreenivasan N., Stefansson S., Farrell D.T., Shaffer W.B. Jr, Geha A.S. Hypothermia can cause errors in activated coagulation time. Anesthesiology. 53:(Suppl 3):1980;85.
14. Nagaoka H., Katori M. Inhibition of Kinin Formation by a Kallikrein inhibitor during extracorporeal circulation in open-heart surgery. Circulation. 52:1975;325-332.
15. Pang L.M., Stalcup S.A., Lipset J.S., Hayes C.J., Bowman F.O. Jr, Mellins R.B. Increased circulating bradykinin during hypothermia and cardiopulmonary bypass in children. Circulation. 60:1979;1503-1507.
16. Ferroni P., Speziale G., Ruvolo G., et al. Platelet activation and cytokine production during hypothermic cardiopulmonary bypass - a possible correlation? Thromb Haemost. 80:1998;58-64.
17. Harker L.A., Malpass T.W., Branson H.E., Hessel E.A. II, Slichter S.J. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass acquired transient platelet dysfunction associated with elective alpha-granule release . Blood. 56:1980;824-834.
18. Rinder C.S., Bohnert J., Rinder H.M., Mitchell J., Ault K.A., Hillmann R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology. 75:1991;388-393.
19. Komai H., Haworth S.G. Effect of cardiopulmonary bypass on the circulating level of soluble GMP-140. Ann Thorac Surg. 58:1994;478-482.
20. Mazer C.D., Hornstein A., Freedman J. Platelet activation in warm and cold heart surgery. Ann Thorac Surg. 59:1995;1481-1486.
21. Kestin A.S., Valeri C.R., Khuri S.F., et al. The platelet function defect of cardiopulmonary bypass. Blood. 82:1993;107-117.
22. Valeri C.R., Feingold H., Cassidy G., et al. Hypothermia-induced reversible platelet dysfunction. Ann Surg. 205:1987;175-181.
23. Van Oeveren W., Harder M.P., Roozendaal K.J., Eijsman L., Wildevuur C.R.H. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 99:1990;788-797.
24. Holloway D.S., Summaria L., Sandesara J., Vagher J.P., Alexander J.C., Caprini J.A. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thrombosis Haemostasis. 59:1988;62-67.
25. Gans H., Lillehei C.W., Krivit W., Runyan A., MacAulay M., Gans M.A. Problems in hemostasis during open-heart surgery. I. On the release of plasminogen activator. Ann Surg. 154:1961;915-924.
26. Kucuk O., Kwaan H.C., Frederickson J., Wade L., Green D. Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation. Am J Hematol. 23:1986;223-229.
27. Yoshihara H., Yamamoto T., Mihara H. Changes in coagulation and fibrinolysis occurring in dogs during hypothermia. Thrombos Res. 37:1985;503-512.
28. Gott V.L., Gillinov A.M., Pyeritz R.E., et al. Aortic root replacement risk factor analysis of a seventeen-year experience with 270 patients . J Thorac Cardiovasc Surg. 109:1995;536-545.
29. Svensson L.G., Crawford E.S., Hess K.R., et al. Deep hypothermia with circulatory arrest determinants of stroke and early mortality in 656 patients . J Thorac Cardiovasc Surg. 106:1993;19-31.
30. Ergin M.A., Galla J.D., Lansman S.L., Quintana C., Bodian C., Griepp R.B. Hypothermic circulatory arrest in operations on the thoracic aorta. J Thorac Cardiovasc Surg. 107:1994;788-799.
31. Laas J., Jurmann M.J., Heinemann M., Borst H.G. Advances in aortic arch surgery. Ann Thorac Surg. 53:1992;227-232.
32. Crawford E.S., Kirklin J.W., Naftel D.C., Svensson L.G., Coselli J.S., Safi H.J. Surgery for acute dissection of ascending aorta. J Thorac Cardiovasc Surg. 104:1992;46-59.
33. Galloway A.C., Colvin S.B., LaMendola C.L., et al. Ten-year operative experience with 165 aneurysms of the ascending aorta and aortic arch. Circulation. 80:(Suppl I):1980;I-249-I-256.
34. Lytle B.W., Mahfood S.S., Cosgrove D.M., Loop F.D. Replacement of the ascending aorta. J Thorac Cardiovasc Surg. 99:1990;651-658.
35. Fann J.I., Sarris G.E., Mitchell R.S., et al. Treatment of patients with aortic dissection presenting with peripheral vascular complications. Ann Surg. 212:1990;705-713.
36. Crawford E.S., Svensson L.G., Coselli J.S., Safi H.J., Hess K.R. Surgical treatment of aneurysm and/or dissection of the ascending aorta, transverse aortic arch, and ascending aorta and transverse aortic arch. J Thorac Cardiovasc Surg. 98:1989;659-674.
37. Westaby S., Forni A., Dunning J., et al. Aprotinin and bleeding in profoundly hypothermic perfusion. Eur J Cardiothorac Surg. 8:1994;82-86.
38. Esmon C.T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biological Chem. 264:1989;4743-4746.
39. Knobl P.N., Zilla P., Rasol R., Muller M., Vukovich T.C. The protein C system in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 94:1987;600-605.
40. Stibbe J., Kluft C., Brommer E.J.P., Gomes M., deJone D., Nauta J. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator. Eur J Clin Invest. 14:1984;375-382.
41. Boldt J., Schindler E., Welters I., Wittstock M., Stertmann W.A., Hempelmann G. The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgery patients. Anaesthesia. 50:1995;954-960.
42. Van Oeveren W., van Oeveren B., Wildevuur R.H. Anticoagulation policy during use of aprotinin in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 104:1992;210-211.
43. DeSmet A.A., Joen M.C.N., van Oeveren W., et al. Increased anti-coagulation during cardiopulmonary bypass by aprotinin. J Thorac Cardiovasc Surg. 100:1990;520-527.
44. Sundt T.M. II, Kouchoukos N.T., Saffitz J.E., Murphy S.F., Wareing T.H., Stahl D.J. Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. Ann Thorac Surg. 55:1993;1418-1424.
45. Dietrich W., Mossinger H., Spannagl M., et al. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg. 105:1993;712-720.
46. Goldstein D.J., DeRosa C.M., Mongero L.B., et al. Safety and efficacy of aprotinin under conditions of deep hypothermia and circulatory arrest. J Thorac Cardiovasc Surg. 110:1995;1615-1622.
47. Okita Y., Takamoto S., Ando M., Morota T., Yamaki F., Kawashima Y. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation. Circulation. 94:(Suppl II):1996;177-181.
48. Parolari A., Antona C., Alamanni F., et al. Aprotinin and deep hypothermic circulatory arrest there are no benefits even when appropriate amounts of heparin are given . Eur J Cardiothorac Surg. 11:1997;149-156.
49. Ehrlich M., Grabenwoger M., Cartes-Zumelzu F., et al. Operations on the thoracic aorta and hypothermic circulatory arrest is aprotinin safe? J Thorac Cardiovasc Surg. 115:1998;220-225.
50. Godet G., Fleron M.H., Vicaut E., et al. Risk factors for acute postoperative renal failure in thoracic or thoracoabdominal aortic surgery a prospective study . Annesth Analg. 85:1997;1227-1232.
51. Saffitz J.E., Stahl D.J., Sundt T.M., Wareing T.H., Kouchoukos N.T. Disseminated intravascular coagulation after administration of aprotinin in combination with deep hypothermic circulatory arrest. Am J Cardiol. 72:1993;1080-1082.
52. Wang J.S., Lin C.Y., Hung W.T., Thisted R.A., Karp R.B. In vitro effects of aprotinin on activated clotting time measured with different activators. J Thorac Cardiovasc Surg. 104:1992;1135-1140.
53. Hunt B.J., Segal H.C., Yacoub M. Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass [letter]. J Thorac Cardiovasc Surg. 104:1992;211-212.
54. Smith C.R., Mongero L.B., DeRosa C.M., et al. Safety of aprotinin in profound hypothermia and circulatory arrest [letter]. Ann Thorac Surg. 58:1994;603-609.
55. Dietrich W., Dilthey G., Spannagl M., et al. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. Anesthesiology. 83:1995;679-689.
56. Dietrich W., Jochum M. Effect of celite and kaolin on activated clotting time in the presence of aprotinin activated clotting time is reduced by binding of aprotinin to kaolin . J Thorac Cardiovasc Surg. 109:1995;177-178.
57. Dietrich W., Mossinger H. The use if aprotinin in pediatric cardiopulmonary bypass. Pifarre R. Blood Conservation with Aprotinin. 1995;275-286 Hanley and Belfus, Philadelphia.
58. Kipfer B., Striffeler H., Gersbach P., et al. Surgery for acute ascending aortic dissection closed versus open distal aortic repair . Euro J Cardiothoracic Surg. 9:1995;248-252.
59. Rooney S.J., Pagano D., Bognolo G., Wong C., Bonser R.S. Aprotinin in aortic surgery requiring profound hypothermia and circulatory arrest. Euro J Cardiothorac Surg. 11:1997;373-378.
60. Regragui I.A., Bryan A.J., Izzat M.B., Wisheart J.D., Hutter J.A., Angelini G.D. Aprotinin use with hypothermic circulatory arrest for aortic valve and thoracic aortic surgery renal function and early survival . J Heart Valve Dis. 4:1995;674-677.
61. Moreno-Cabral C.E., Miller D.C., Mitchell R.S., Stinson E.B., Oyer P.E., Jamieson S.W. Degenerative and atherosclerotic aneurysms of the thoracic aorta. J Thorac Cardiovasc Surg. 88:1984;1020-1032.
62. Schepens M.A., Defauw J.J., Hamerlijinck R.P., Vermeulen F.E. Risk assessment of acute renal failure after thoracoabdominal aortic aneurysm surgery. Ann Surg. 219:1994;400-407.
63. Svensson L.G., Crawford E.S., Hess K.R., Cosselli J.S., Safi H.J. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg. 17:1993;357-370.
64. Crawford E.S., Crawford J.L., Safi H.J., et al. Thoracoabdominal aortic aneurysms preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients . J Vasc Surg. 3:1986;389-404.
65. Coselli J.S. Thoracoabdominal aortic aneurysms experience with 372 patients . J Cardiovasc Surg. 9:1994;638-647.
66. Raudkivi P.J., Williams J.D., Monro J.L., Ross J.K. Surgical treatment of the ascending aorta. J Thorac Cardiovasc Surg. 98:1989;675-682.